Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung CancerAnna F. Farago, Benjamin J. Drapkin, David A. Barbie et al.|Cancer Discovery|2019Cited by 238
Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived XenograftsBenjamin J. Drapkin, Anna F. Farago, Julie George et al.|Cancer Discovery|2018Cited by 216
Safety and efficacy of combination olaparib (O) and temozolomide (T) in small cell lung cancer (SCLC).Anna F. Farago, Alice T. Shaw, Benjamin J. Drapkin et al.|Journal of Clinical Oncology|2018Cited by 8
Abstract 2972: Co-clinical trial of olaparib and temozolomide in SCLC PDX models uncovers new biomarkers of sensitivityBenjamin J. Drapkin, Nicholas J. Dyson, Roman K. Thomas et al.|Cancer Research|2018Cited by 1